Chris Hindson is currently the Executive Director of Managed Markets Oncology at Gilead Sciences, a role they began in 2022. Previously, Chris served as the Executive Business Director at Novartis Oncology from 2020 to 2022 and held various positions at GlaxoSmithKline, including Area Development Manager and Payer Marketing Manager. They have also contributed to market access in specialty divisions and led sales training for vaccine initiatives. Chris earned a degree in Marketing from George Mason University, graduating in 1998.
This person is not in the org chart
This person is not in any teams
This person is not in any offices